1. Gelb, D. J., Oliver, E., & Gilman, S. (1999). Diagnostic criteria for Parkinson disease. Archives of Neurology,56(1), 33–39.
https://doi.org/10.1001/archneur.56.1.33
.
2. Koller, W. C., Langston, J., Hubble, J., Irwin, I., Zack, M., Golbe, L., et al. (1991). Does a long preclinical period occur in Parkinson's disease? Neurology,41(52), 8–13.
https://doi.org/10.1212/WNL.41.5_Suppl_2.8
.
3. Mozley, P. D., Schneider, J. S., Acton, P. D., et al. (2000). Binding of [99mTc] TRODAT to dopamine transporters in patients with Parkinson's disease and in healthy volunteers. Journal of Nuclear Medicine,41(4), 584–589.
4. Chou, K., Hurtig, H., Stern, M., Colcher, A., Ravina, B., Newberg, A., et al. (2004). Diagnostic accuracy of [99m Tc] TRODAT-1 SPECT imaging in early Parkinson's disease. Parkinsonism & Related Disorders,10(6), 375–379.
https://doi.org/10.1016/j.parkreldis.2004.04.002
.
5. Hwang, W. J., Yao, W. J., Wey, S. P., & Ting, G. (2004). Reproducibility of 99mTc-TRODAT-1 SPECT measurement of dopamine trans-porters in Parkinson’s disease. Journal of nuclear medicine,45(2), 207–213.